Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Coronavirus

BHIVA ‘2nd COVID peak’ guidance for HIV clinics - plain English version

Editor's pick
BHIVA
8 October 2020
Weight gain & lipodystrophy

Weight gain after switch to an integrase inhibitor does not boost 'bad fat'

News
7 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
Weight gain & lipodystrophy

Weight gain on HIV treatment: what is normal, and what is harmful?

News
7 October 2020
Injectable & long-acting HIV treatment

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey

News
5 October 2020
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
Ageing & HIV

aidsmapLIVE: A long life with HIV Video

October 2020
Clinical trials

No more excuses: Making HIV research work for women

Editor's pick
Sophia Forum
29 September 2020
Diabetes

HIV drugs could prevent diabetes, study suggests

Editor's pick
EurekAlert
24 September 2020
Adherence

Tanzania: Financial incentives improve HIV viral suppression, retention in care

Editor's pick
Healio
18 September 2020
HIV treatment for children & young people

Adult doses of dolutegravir can be used by children weighing 20 kg or more

News
15 September 2020
PrEP science

Q&A: What clinicians should know about starting, stopping and restarting PrEP

Editor's pick
Healio
14 September 2020
Improving HIV care

HIV programmes in Africa need new models of care for people’s first six months on treatment

News
14 September 2020
Health problems & ageing

Among Women, HIV Is Tied to High Rates of Chronic Health Conditions

Editor's pick
POZ
11 September 2020
Weight gain & lipodystrophy

Switch From Efavirenz to Integrase Strand Transfer Inhibitors Related to Weight Gain

Editor's pick
Infectious Disease Advisor
11 September 2020
Diabetes

No increased risk of diabetes with integrase inhibitors in people starting HIV treatment

News
11 September 2020
PrEP science

Trans and cis women and men all have similar levels of PrEP drugs in blood, directly observed dosing study finds

News
7 September 2020
PrEP science

Two different cases of PrEP failure despite high adherence underline that such events are rare, but should not be ignored

News
4 September 2020
Resistance

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital

Editor's pick
EurekAlert
3 September 2020
New & experimental HIV treatments

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

Editor's pick
POZ
2 September 2020
Starting treatment

Dovato Shows Promise as a Rapid Test-and-Treat HIV Regimen

Editor's pick
POZ
1 September 2020
Resistance

Darunavir Resistance Development Is Rare in HIV Treatment

Editor's pick
Infectious Disease Advisor
1 September 2020